MARKET

NTRBW

NTRBW

Nutriband
NASDAQ
0.7700
0.0000
0.00%
Closed 09:30 06/26 EDT
OPEN
0.7700
PREV CLOSE
0.7700
HIGH
0.7700
LOW
0.7700
VOLUME
9
TURNOVER
--
52 WEEK HIGH
4.500
52 WEEK LOW
0.7700
MARKET CAP
--
P/E (TTM)
-0.2932
1D
5D
1M
3M
1Y
5Y
1D
Nutriband Secures New Three-Year $5M Credit Facility
TipRanks · 6d ago
Nutriband amends $5 million credit line facility at 7% interest
PUBT · 6d ago
NUTRIBAND - CREDIT LINE DOES NOT PERMIT CONVERSION OF OUTSTANDING AMOUNTS INTO COMMON STOCK - SEC FILING
Reuters · 6d ago
Weekly Report: what happened at NTRB last week (0615-0619)?
Weekly Report · 6d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 06/18 21:06
Weekly Report: what happened at NTRB last week (0608-0612)?
Weekly Report · 06/15 10:40
Nutriband Q1 EPS $(0.10) Up From $(0.12) YoY, Sales $433.399K Down From $667.432K YoY
Benzinga · 06/11 21:16
Nutriband FY27 Q1 net loss narrows to $1.24 million; revenue falls to $433,399
PUBT · 06/11 20:21
More
About NTRBW
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

Webull offers Nutriband Inc stock information, including NASDAQ: NTRBW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTRBW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTRBW stock methods without spending real money on the virtual paper trading platform.